Showing results (861-870 of 3,769) with videos related to

Sort By:
Pageof 377
Radiation Oncology (London, England)|March 6, 2024
Repeatability quantification of brain diffusion-weighted imaging for future clinical implementation at a low-field MR-linacMoritz Rabe, Olaf Dietrich, Robert Forbrig, et al.
Radiation Oncology (London, England)|March 4, 2024
High-volume prostate biopsy core involvement is not associated with an increased risk of cancer recurrence following 5-fraction stereotactic body radiation therapy monotherapyJonathan W Lischalk, Astrid Sanchez, Vianca F Santos, et al.
Radiation Oncology (London, England)|November 8, 2023
Dose escalation for stereotactic arrhythmia radioablation of recurrent ventricular tachyarrhythmia - a phase II clinical trialBoldizsar Kovacs, Michael Mayinger, Stefanie Ehrbar, et al.
Radiation Oncology (London, England)|November 11, 2023
Use of focal radiotherapy boost for prostate cancer: radiation oncologists' perspectives and perceived barriers to implementationAllison Y Zhong, Asona J Lui, Matthew S Katz, et al.
Radiation Oncology (London, England)|November 11, 2023
First clinical application of image-guided intraoperative electron radiation therapy with real time intraoperative dose calculation in recurrent rectal cancer: technical procedureFalk Roeder, Gerd Fastner, Christoph Fussl, et al.
Radiation Oncology (London, England)|July 26, 2023
Radiotherapy-induced diffuse myocardial fibrosis in early-stage breast cancer patients - multimodality imaging study with six-year follow-upMikko Moisander, Tanja Skyttä, Sari Kivistö, et al.
Radiation Oncology (London, England)|July 11, 2023
HLA-DQA1 expression is associated with prognosis and predictable with radiomics in breast cancerJingYu Zhou, TingTing Xie, HuiMing Shan, et al.
Radiation Oncology (London, England)|July 18, 2023
Postoperative adjuvant radiotherapy for patients with upper tract urothelial carcinoma (UTUC) who underwent kidney-sparing surgery (KSS): a single-center studyHui Guan, Guangyu Wang, Weiping Wang, et al.
Radiation Oncology (London, England)|July 4, 2023
Real-world outcomes of PD-L1 inhibitors combined with thoracic radiotherapy in the first-line treatment of extensive stage small cell lung cancerJianfeng Peng, Lemeng Zhang, Liping Wang, et al.
Radiation Oncology (London, England)|July 28, 2023
Circulating miR-21 as a prognostic biomarker in HCC treated by CT-guided high-dose rate brachytherapyMatthias Stechele, Henrike Link, Heidrun Hirner-Eppeneder, et al.
Pageof 377